Acellular tissue matrices made from galactose alpha-1,3-galactose-deficient tissue

Details for Australian Patent Application No. 2004259019 (hide)

Owner LifeCell Corporation

Inventors Griffey, Edward S.; McQuillan, David J.; Beniker, Herbert Daniel; Xu, Hui

Agent Pizzeys

Pub. Number AU-B-2004259019

PCT Pub. Number WO2005/009134

Priority 60/489,245 21.07.03 US

Filing date 21 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 23 September 2010

International Classifications

A01N 63/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing micro-organisms, viruses, microbial fungi, animals, e.g. nematodes, or substances produced by, or obtained from micro-organisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates

A01K 67/033 (2006.01) Rearing or breeding animals, not otherwise provided for

A61F 2/02 (2006.01) Filters - Prostheses implantable into the body

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009134 Priority application(s): WO2005/009134

23 September 2010 Application Accepted

  Published as AU-B-2004259019

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259024-Compounds for inflammation and immune-related uses

2004259014-Antibiotic compound